Publications/Findings

Thirty-three peer-reviewed papers have been published from CEASAR to date. PDF copies of these papers are available for download below: 

• Al Hussein Al Awamlh B, Wallis CJD, Penson DF, Huang LC, Zhao Z, Conwill R, Talwar R, Morgans AK, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, O'Neil BB, Koyama T, Hoffman KE, Barocas DA. Functional Outcomes After Localized Prostate Cancer Treatment. JAMA. 2024 Jan 23;331(4):302-317. doi: 10.1001/jama.2023.26491. PMID: 38261043


• Al Hussein Al Awamlh B, Wallis CJD, Diehl C, Barocas DA, Beskow LM. The lived experience of prostate cancer: 10-year survivor perspectives following contemporary treatment of localized prostate cancer. J Cancer Surviv. 2023 May 12. doi: 10.1007/s11764-023-01381-6. Epub ahead of print. PMID: 37171717.


• Tallman JE, Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Hoffman KE, Barocas DA. Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer. Prostate Cancer Prostatic Dis. 2022 Dec 8. doi: 10.1038/s41391-022-00627-1. Epub ahead of print. Erratum in: Prostate Cancer Prostatic Dis. 2023 Mar 8;: PMID: 36482081.


• Samora NL, Wallis CJD, Huang LC, Tallman JE, Zhao Z, Hoffman K, Morgans A, Cooperberg M, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan S, O'Neil B, Paddock LE, Stroup A, Wu XC, Koyama T, Penson DF, Barocas DA. Association between body mass index and localized prostate cancer management and disease-specific quality of life. BJUI Compass. 2022 Nov 2;4(2):223-233. doi: 10.1002/bco2.197. PMID: 36816144; PMCID: PMC9931544


• Joyce DD, Wallis CJD, Huang LC, Hoffman KE, Zhao Z, Koyama T, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate Cancer. JNCI Cancer Spectr. 2022 Nov 1;6(6):pkac071. doi: 10.1093/jncics/pkac071. PMID: 36255249; PMCID: PMC9731205.


• De B, Pasalic D, Barocas DA, Wallis CJD, Huang LC, Zhao Z, Koyama T, Tang C, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Hoffman KE. Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study. J Urol. 2022 Dec;208(6):1226-1239. doi: 10.1097/JU.0000000000002902. Epub 2022 Aug 25. Erratum in: J Urol. 2023 Feb;209(2):450. PMID: 36006050; PMCID: PMC9933910.


• Tallman JE, Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA, Hoffman KE. Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):80-87. doi: 10.1038/s41391-022-00518-5. Epub 2022 Feb 25. Erratum in: Prostate Cancer Prostatic Dis. 2023 Mar 13;: PMID: 35217831.


• Luckenbaugh AN, Wallis CJD, Huang LC, Wittmann D, Klaassen Z, Zhao Z, Koyama T, Laviana AA, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Hoffman KE, Penson DF, Barocas DA. Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes. J Urol. 2022 May;207(5):1029-1037. doi: 10.1097/JU.0000000000002370. Epub 2022 Mar 3. PMID: 34978488; PMCID: PMC9933911.


• Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Kaplan SH, Greenfield S, Luckenbaugh AN, Klaassen Z, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Hoffman KE, Barocas DA. Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer. JAMA Oncol. 2022 Jan 1;8(1):50-59. doi: 10.1001/jamaoncol.2021.5160. PMID: 34792527; PMCID: PMC8603232.


• Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Tallman JE, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA, Hoffman KE. Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external beam-radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort. Urol Oncol. 2022 Feb;40(2):56.e1-56.e8. doi: 10.1016/j.urolonc.2021.04.035. Epub 2021 Jun 19. PMID: 34154899; PMCID: PMC9933913.


• Joyce DD, Wallis CJD, Luckenbaugh AN, Huelster HL, Zhao Z, Hoffman KE, Huang LC, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, Neil BBO, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):238-247. doi: 10.1038/s41391-021-00405-5. Epub 2021 Jun 9. PMID: 34108648.


• Pasalic D, Barocas DA, Huang LC, Zhao Z, Koyama T, Tang C, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup AM, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Hoffman KE. Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer. Cancer. 2021 Jun 1;127(11):1912-1925. doi: 10.1002/cncr.33388. Epub 2021 Feb 17. PMID: 33595853.


• Stone BV, Laviana AA, Luckenbaugh AN, Huang LC, Zhao Z, Koyama T, Conwill R, Hoffman K, Joyce DD, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer. J Urol. 2021 Mar;205(3):761-768. doi: 10.1097/JU.0000000000001423. Epub 2020 Nov 30. PMID: 33252300.


• Reisz PA, Laviana AA, Zhao Z, Huang LC, Koyama T, Conwill R, Hoffman K, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR Study J Urol. 2020 Dec;204(6):1236-1241. doi: 10.1097/JU.0000000000001198. Epub 2020 Jun 22. PMID: 32568605.


• Huelster HL, Laviana AA, Joyce DD, Huang LC, Zhao Z, Koyama T, Hoffman KE, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg M, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes. Urol Oncol. 2020 Dec;38(12):930.e23-930.e32. doi: 10.1016/j.urolonc.2020.06.022. Epub 2020 Jul 29. PMID: 32736934; PMCID: PMC8095316.


• Laviana AA, Zhao Z, Huang LC, Koyama T, Conwill R, Hoffman K, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation. Eur Urol. 2020 Aug;78(2):248-255. doi: 10.1016/j.eururo.2020.02.007. Epub 2020 Feb 22. PMID: 32098731; PMCID: PMC7384934.


• Hoffman KE, Penson DF, Zhao Z, Huang LC, Conwill R, Laviana AA, Joyce DD, Luckenbaugh AN, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Koyama T, Barocas DA. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer. JAMA. 2020 Jan 14;323(2):149-163. doi: 10.1001/jama.2019.20675. PMID: 31935027; PMCID: PMC6990712.


• Laviana AA, Hernandez A, Huang LC, Zhao Z, Koyama T, Conwill R, Hoffman K, Feurer ID, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Interpretation of Domain Scores on the EPIC - How Does the Domain Score Translate into Functional Outcomes? J Urol. 2019 Dec;202(6):1150-1158. doi: 10.1097/JU.0000000000000392. Epub 2019 Jun 19. Erratum in: J Urol. 2021 Jul;206(1):178. PMID: 31216252; PMCID: PMC8627681.


• Barocas DA, Penson DF; CEASAR Investigators. Functional Recovery Following Primary Treatment for Prostate Cancer: Update from the CEASAR Study. 2020 Mar 15;6(2):205-207. doi: 10.1016/j.euf.2019.04.001. Epub 2019 May 7. PMID: 31072805.


• Lee DJ, Zhao Z, Huang LC, Koyoma T, Resnick MJ, Penson DF, Barocas DA, Hoffman KE. Racial variation in receipt of quality radiation therapy for prostate cancer. Cancer Causes Control. 2018 Oct;29(10):895-899. doi: 10.1007/s10552-018-1065-5. Epub 2018 Aug 11. PMID: 30099628.


• Lee DJ, Barocas DA, Zhao Z, Huang LC, Resnick MJ, Koyoma T, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF, Hoffman KE.Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam with Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer. 2018 Sep 1;102(1):116-126. doi: 10.1016/j.ijrobp.2018.05.043. Epub 2018 Jun 1. PMID: 30102188; PMCID: PMC7492102.


• Lee DJ, Barocas DA, Zhao Z, Huang LC, Koyama T, Resnick MJ, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF, Hoffman KE. Contemporary prostate cancer radiation therapy in the United States: Patterns of care and compliance with quality measures. Pract Radiat Oncol. 2018 Sep-Oct;8(5):307-316. doi: 10.1016/j.prro.2018.04.009. PMID: 30177030; PMCID: PMC7492101.


• Tyson MD 2nd, Koyama T, Lee D, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen V, Conwill R, McCollum D, Penson DF, Barocas DA. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results. Eur Urol. 2018 Jul;74(1):26-33. doi: 10.1016/j.eururo.2018.02.012. Epub 2018 Feb 28. PMID: 29501451; PMCID: PMC7643873.


• Avulova S, Zhao Z, Lee D, Huang LC, Koyama T, Hoffman KE, Conwill RM, Wu XC, Chen V, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Resnick MJ, Penson DF, Barocas DA. The Effect of Nerve Sparing Status on Sexual Function: 3-Year Results from the CEASAR Study. J Urol. 2018 May;199(5):1202-1209. doi: 10.1016/j.juro.2017.12.037. Epub 2017 Dec 16. Erratum in: J Urol. 2018 Aug;200(2):458. PMID: 29253578.


• Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF. Association Between Radiation Therapy, Surgery or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years. JAMA. 2017 Mar 21;317(11):1126-1140. doi: 10.1001/jama.2017.1704. Erratum in: JAMA. 2017 May 23;317(20):2134. PMID: 28324093; PMCID: PMC5782813.


• Lang MF, Tyson MD, Alvarez JR, Koyama T, Hoffman KE, Resnick MJ, Cooperberg MR, Wu XC, Chen V, Paddock LE, Hamilton AS, Hashibe M, Goodman M, Greenfield S, Kaplan SH, Stroup A, Penson DF, Barocas DA. The Infuence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort.  2017 May;103:173-178. doi: 10.1016/j.urology.2016.12.063. Epub 2017 Feb 9. PMID: 28189554; PMCID: PMC5410889.


• Tyson MD, Alvarez J, Koyama T, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen VW, Penson DF, Barocas DA. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study. Eur Urol. 2017 Aug;72(2):307-314. doi: 10.1016/j.eururo.2016.10.036. Epub 2016 Nov 3. PMID: 27816300; PMCID: PMC5413424.


• Eifler JB, Alvarez J, Koyama T, Conwill RM, Ritch CR, Hoffman KE, Resnick MJ, Penson DF, Barocas DA; Collaborators. More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades. J Urol. 2017 Mar;197(3 Pt 1):614-620. doi: 10.1016/j.juro.2016.10.067. Epub 2016 Oct 27. PMID: 27984110; PMCID: PMC5315642.


• Sohn W, Resnick MJ, Greenfield S, Kaplan SH, Phillips S, Koyama T, Goodman M, Hamilton AS, Hashibe M, Hoffman KE, Paddock LE, Stroup AM, Wu XC, Penson DF, Barocas DA. Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications. Med Care. 2016 Aug;54(8):738-44. doi: 10.1097/MLR.0000000000000562. PMID: 27219634; PMCID: PMC4945364.


• O'Neil B, Koyama T, Alvarez J, Conwill RM, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, Stanford JL, Stroup AM, Paddock LE, Wu XC, Stephenson RA, Resnick MJ, Barocas DA, Penson DF. The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples. J Urol. 2016 Feb;195(2):321-9. doi: 10.1016/j.juro.2015.08.092. Epub 2015 Sep 3. PMID: 26343985; PMCID: PMC4916911.


• Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Koyama T, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, McCollum D, Paddock LE, Stanford JL, Stroup AM, Wu XC, Penson DF. The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Eur Urol. 2015 Jun;67(6):1019-1025. doi: 10.1016/j.eururo.2014.08.035. Epub 2014 Aug 28. PMID: 25174325; PMCID: PMC4412750.


• Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Chen VW, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Koyama T, Penson DF. Contemporary Prevalence of Pretreatment Urinary, Sexual, Hormonal, and Bowel Dysfunction: Defining the Population at Risk for Harms of Prostate Cancer Treatment. Cancer. 2014 Apr 15;120(8):1263-71. doi: 10.1002/cncr.28563. Epub 2014 Feb 7. PMID: 24510400; PMCID: PMC4930672.


• Barocas DA, Chen V, Cooperberg M, Goodman M, Graff JJ, Greenfield S, Hamilton A, Hoffman K, Kaplan S, Koyama T, Morgans A, Paddock LE, Phillips S, Resnick MJ, Stroup A, Wu XC, Penson DF. Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study. J Comp Eff Res. 2013 Jul;2(4):445-60. doi: 10.2217/cer.13.34. PMID: 24236685; PMCID: PMC4920086.